- Infants Hospitalized With RSV-LRTI at Risk For Lung Abnormalities at Age 2
- Using Inhaled Corticosteroids in COPD Increases Tuberculosis, Pneumonia Rates
- Atopic Dermatitis Tied to Higher Venous Thromboembolism Risk
- Vitamin D₃ Supplements Not Tied to Lower Cancer Mortality, Overall
- Aspirin Use Associated With Reduced Mortality After ICU Stay
- FDA Concerned Over Compounded Semaglutide Following Reports of Adverse Events
- SGLT2 Inhibitor Use and Risk for ASCVD Events in Type 2 Diabetes
- Roflumilast Foam Efficacious for Treating Seborrheic Dermatitis
- Biomarker-Guided ICI Therapy Provides Greater Benefit in Cancer Patients
- Low Immunity Against COVID-19 Omicron Variants Despite 3 Vaccine Doses in Hematologic Malignancies
- Precision Medicine in Severe Asthma Predicts Lack of Benefit From Biologics
- Patients With COPD on Triple vs Dual Therapy Have 7% Lower Exacerbation Risk
Clinical Tools
Powered by
Powered by 
MEDI1191 Plus Durvalumab Appears Safe, Active in Advanced Solid Tumors
Rinvoq Approved for Moderately to Severely Active Crohn Disease
Baricitinib Continuously Improves Hair Regrowth in Severe Alopecia Areata
Guided Dose Reduction May Help Decrease Medication Dose in Schizophrenia
Substantial Weight Loss Reductions Observed With Tirzepatide in T2D Patients
